Name the object of each statement
Draw two columns headed compound information and finished-product claim. A statement about CBD as a compound belongs in the first; a promise about a named bottle or preparation belongs in the second. Do not assume evidence transfers automatically between them. The name of a compound does not tell you every ingredient, concentration, quality characteristic or regulatory detail of a commercial product.
Use an invented advertisement for practice and remove any real brand from your notes. Highlight which words identify the material and which words promise an outcome. This is a reading exercise for Zimbabwean audiences, not a shopping comparison. No purchase, sample collection, opening of a product or communication with a seller is required to understand the distinction.
Read historical statements within their scope
WHO’s December 2017 CBD questions and answers addressed an international scheduling discussion about CBD in a specified context. It is historical material, not a blanket current safety certificate. Keep its date and purpose beside any note you make. Quoting a favourable fragment without those boundaries can change what the original statement meant.
The FDA’s consumer update discusses risks and uncertainties surrounding cannabis-derived compounds and products. Its US approval framework does not determine local permission in Zimbabwe. The useful reading habit is to ask which exact object and question a source addresses. Do not combine a historical international statement and a foreign regulatory page into a new unsupported claim that any locally advertised preparation is safe or approved.
List the missing links in the advertisement
Create a question list covering identity, the evidence cited, who produced it and what claim it supports. A label or laboratory-looking document does not answer every question. If a report is shown, ask whether its identity and scope actually match the product and statement. This tutorial does not teach laboratory testing, authenticate certificates or provide a method for deciding a product is suitable to use.
Separate quality, clinical evidence and local regulatory status. Evidence relating to one does not settle the others. A statement that a material contains a named compound is not proof that it treats a condition, and an overseas market listing is not Zimbabwean authorisation. Keep each unresolved point in its own box rather than letting one reassuring phrase stand in for all three.
Write a careful conclusion
Draft a short note explaining which statement you can understand and which product claims remain unsupported by the material you inspected. If personal health is involved, discuss the claim with a qualified clinician rather than using the note to choose a regimen. For local regulatory questions, seek the appropriate authority’s current guidance. The site cannot supply approval, legal advice or treatment review.
Keep the source links, dates and the exact claim with the note. Avoid circulating private medical information or endorsing a seller because its advertisement uses scientific terminology. No growing, manufacture, sourcing, dosing or use instructions are provided. The exercise is complete when you can explain why general information about a compound does not establish every promise made about a finished product.
Sources & further reading
Use these references to check the underlying guidance and any current local requirements. Practical worksheets and illustrative examples in this guide are original educational material.
- WHO: Cannabidiol questions and answers, 19 December 2017 (historical)
- US FDA: Consumer information about cannabis-derived compounds and CBD
- CDC: About Cannabis
This guide is general information. Source notes are not a claim of independent professional review.